Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gion

Showing results (91-100 of 121) with videos related to

Pageof 13
Sort By:
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|December 1, 1995
How alternative are immunoassay systems employing non-radioisotopic labels? A comparative appraisal of their main analytical characteristicsD Pelizzola, E Bombardieri, A Brocchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Appropriateness of the use of clinical and radiologic examinations and laboratory tests in the follow-up of surgically-treated breast cancer patients. Results of the Working Group on the Clinical Aspects of Follow-upF Boccardo, P Bruzzi, L Cionini, et al.
Tumori|October 31, 1989
Tumor markers in serum of patients with primary squamous cell carcinoma of the esophagusM Gion, C Tremolada, R Mione, et al.
The International Journal of Biological Markers|January 1, 1990
Tumor markers in squamous cell carcinoma of esophagus: immunometric assay in cytosol and membrane fractionM Gion, C Tremolada, R Mione, et al.
The International Journal of Biological Markers|January 1, 1993
A new approach to tumour marker assessment by perioperative determination in breast and colorectal cancerM Gion, G Ruggeri, R Mione, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Comparison between single saturating dose ligand binding assay and enzyme immunoassay for low-salt extractable oestrogen and progesterone receptors in breast cancer: a multicentre studyM Gion, R Dittadi, A E Leon, et al.
Anticancer Research|September 1, 1993
Comparison between western blotting, immunohistochemical and ELISA assay for p185neu quantitation in breast cancer specimensR Dittadi, L Catozzi, M Gion, et al.
European Urology|January 1, 1995
Prostate-specific antigen as a unique routine test in monitoring therapy for inoperable prostate cancer: comparison with radionuclide bone scan and prostatic acid phosphataseM Barichello, M Gion, A Bonazza, et al.
Breast (Edinburgh, Scotland)|October 1, 2013
Phase II study of liposome-encapsulated doxorubicin plus cyclophosphamide, followed by sequential trastuzumab plus docetaxel as primary systemic therapy for breast cancer patients with HER2 overexpression or amplificationS Saracchini, L Foltran, F Tuccia, et al.
The International Journal of Biological Markers|October 26, 2005
Comparison between two methods in the determination of circulating chromogranin A in neuroendocrine tumors (NETs): results of a prospective multicenter observational studyA Leon, M Torta, R Dittadi, et al.
Pageof 13

Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|December 1, 1995
How alternative are immunoassay systems employing non-radioisotopic labels? A comparative appraisal of their main analytical characteristicsD Pelizzola, E Bombardieri, A Brocchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Appropriateness of the use of clinical and radiologic examinations and laboratory tests in the follow-up of surgically-treated breast cancer patients. Results of the Working Group on the Clinical Aspects of Follow-upF Boccardo, P Bruzzi, L Cionini, et al.
Tumori|October 31, 1989
Tumor markers in serum of patients with primary squamous cell carcinoma of the esophagusM Gion, C Tremolada, R Mione, et al.
The International Journal of Biological Markers|January 1, 1990
Tumor markers in squamous cell carcinoma of esophagus: immunometric assay in cytosol and membrane fractionM Gion, C Tremolada, R Mione, et al.
The International Journal of Biological Markers|January 1, 1993
A new approach to tumour marker assessment by perioperative determination in breast and colorectal cancerM Gion, G Ruggeri, R Mione, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Comparison between single saturating dose ligand binding assay and enzyme immunoassay for low-salt extractable oestrogen and progesterone receptors in breast cancer: a multicentre studyM Gion, R Dittadi, A E Leon, et al.
Anticancer Research|September 1, 1993
Comparison between western blotting, immunohistochemical and ELISA assay for p185neu quantitation in breast cancer specimensR Dittadi, L Catozzi, M Gion, et al.
European Urology|January 1, 1995
Prostate-specific antigen as a unique routine test in monitoring therapy for inoperable prostate cancer: comparison with radionuclide bone scan and prostatic acid phosphataseM Barichello, M Gion, A Bonazza, et al.
Breast (Edinburgh, Scotland)|October 1, 2013
Phase II study of liposome-encapsulated doxorubicin plus cyclophosphamide, followed by sequential trastuzumab plus docetaxel as primary systemic therapy for breast cancer patients with HER2 overexpression or amplificationS Saracchini, L Foltran, F Tuccia, et al.
The International Journal of Biological Markers|October 26, 2005
Comparison between two methods in the determination of circulating chromogranin A in neuroendocrine tumors (NETs): results of a prospective multicenter observational studyA Leon, M Torta, R Dittadi, et al.
Pageof 13